Update Conference on Mantle Cell Lymphoma

Department of Oncology at HUSJR and the Institut d’Investigació Sanitària Pere Virgili (IISPV)

🧬 Mantle cell lymphoma (MCL) is a rare type of non-Hodgkin B-cell lymphoma, accounting for approximately 5–7% of all lymphomas. It originates in a specific area of the lymph node called the mantle zone, and typically affects older individuals, especially men.

📈 The prognosis has improved in recent years thanks to advances in molecular diagnostics and targeted therapies, although it remains a challenging lymphoma that requires a personalized and multidisciplinary approach.

📅 This in-person meeting will address the most relevant aspects of the diagnosis and treatment of mantle cell lymphoma, including:

The latest developments in molecular biology
Therapeutic options in first and second line
The emerging role of CAR-T cell immunotherapy

🤝 An excellent opportunity to update knowledge, share clinical experiences, and build collaborative networks in a top-level academic environment.

✨ We look forward to seeing you!